Balance Sheet Components

6 Months Ended

Jun. 30, 2022

Balance Sheet Related Disclosures [Abstract]

(4) BALANCE SHEET COMPONENTS

Property and Equipment, Net

The following table presents the components of property and equipment, net as of June 30, 2022 and December 31, 2021 (in thousands):


	June 30,			December 31,
	2022			2021
Laboratory equipment	$	979		$	324
Computer hardware and software		303			241
Leasehold improvements		229			229
Furniture and fixtures		166			166
Construction in progress		158			—
Property and equipment, gross		1,835			960
Less: accumulated depreciation and amortization		(205	)		(63	)
Property and equipment, net	$	1,630		$	897

Depreciation and amortization expense was $0.1 million for the three months and six months ended June 30, 2022, and nominal for the three months and six months ended June 30, 2021.

Other Assets

The following table presents the components of other assets as of June 30, 2022 and December 31, 2021 (in thousands):


	June 30,		December 31,
	2022		2021
Long-term prepaid clinical expenses	$	7,012	$	6,694
Long-term prepaid contract manufacturing costs		2,854		2,854
Operating lease right-of-use assets		6,083		1,829
Finance lease right-of-use assets		522		746
Deposits		144		144
Restricted cash		66		—
Total other assets	$	16,681	$	12,267

Accrued Expenses and Other Current Liabilities

The following table presents the components of accrued expenses and other current liabilities as of June 30, 2022 and December 31, 2021 (in thousands):


	June 30,		December 31,
	2022		2021
Accrued clinical and nonclinical study costs	$	4,237	$	4,125
Accrued compensation and related expenses		3,603		3,294
Accrued contract manufacturing		2,811		693
Operating lease liabilities, current		646		313
Accrued professional fees		458		790
Finance lease liabilities, current		429		429
Other		563		257
Total accrued expenses and other current liabilities	$	12,747	$	9,901